• Diagnosis​ Info ​and​ ​General​ ​Questions

  SCD Candidate FT-4202 Named FDA Fast Track, Rare Pediatric Disease

  Posted by Sickle Cell Forum Administrator on March 7, 2020 at 11:52 am

  

  FT-4202, a potential oral treatment for sickle cell disease, has been given fast track and rare pediatric disease designations by the U.S. FDA. Read more here.

  What do you think of this story?

  Sickle Cell Forum Administrator replied 4 years, 2 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply